GOAL:

To save lives and eliminate health disparities.

HOW: 

Improve access to high quality prostate cancer care for all men, with the priority focus on African American, Hispanic and Latino individuals.

WHY: 

Prostate cancer, striking 1 in 8 American men, is the most common and the second most lethal male cancer.

  • Prostate cancer is a leading health care disparity
  • Black (including Hispanic) men are at higher risk of this disease, late diagnosis, poor quality care, and death
  • Early detection saves lives.

WHO CAN PARTICIPATE:

Any man aged 40 and older, living in Massachusetts and interested in a consultation with experts, who use the most advanced approaches to preventing, finding and treating prostate cancer early.

WHAT THIS PROGRAM OFFERS:

Patient advocates who address your questions and upon your request, can coordinate consultations with leading prostate cancer experts.

CONSULTATION OPTIONS: 

  • First expert consultation or a second opinion
  • Virtual (telehealth) or in-person appointments

OUR PROGRAM CAN HELP IF YOU HAVE ANY QUESTIONS ABOUT YOUR PROSTATE HEALTH:

  • Are you interested in prostate cancer prevention and early detection, which is critical for saving lives?
  • Are you looking for more information to decide if screening with PSA blood test is right for you (before or after a discussion with your doctor)?
  • Are you at risk because members of your family (particularly your brother or father) have had prostate cancer?
  • Did you have screening already and have questions about your results?
  • Do you have symptoms, such as difficulties urinating or blood in your urine?
  • Did your doctor recommend for you to have a prostate biopsy, and you would like to learn more about advanced non-invasive tests?
  • Did your doctor tell you that you have prostate cancer, and you are looking for more information about treatment options?
  • Did you experience side effects after biopsy or treatment?
  • Did you have treatment already and have questions about the appropriate next steps, including prevention or early diagnosis of cancer return or progression?

POINT OF CONTACT AND CLINICAL COORDINATOR:

If you have questions or are interested in taking part in this program, please contact Summer Mills at AdMeTech Foundation

LEADERSHIP AND PARTICIPATING PHYSICIANS

FOUNDERS:

Faina Shtern, MD
President and CEO, AdMeTech Foundation

Adam Feldman, MD, MPH
Urologist, Massachusetts General Hospital; Assistant Professor of Surgery, Harvard Medical School; and Director, Combined Harvard Urologic Oncology Fellowship

Quoc-Dien Trinh, MD
Co-Director, Dana-Farber/Brigham and Women’s Prostate Cancer Program; Director, Ambulatory Clinical Operations, Division of Urological Surgery; and Associate Professor of Surgery, Harvard Medical School

OTHER SELECTED PARTICIPATING EXPERTS (in alphabetical order):

 

Ryan E. Frankel, MD
Greater Boston Urology

Ikenna Madueke, MD, PhD
Urologist and Fellow, Combined Harvard Program in Urologic Oncology, Massachusetts General Hospital and Brigham & Women’s Hospital, Harvard Medical School

Mitchell Sokoloff, MD
Professor and Chair of Urology, University of Massachusetts Chan Medical School

Stephen Zappala

Stephen Zappala, MD
Clinical Assistant Professor, Department of Urology, Tufts University School of Medicine